Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review

Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd, is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, and structured investments. The company serves life sciences, financial services, health care, specialty glass packaging and real estate sectors. It operates in India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

Feb 04,2020: Piramal Enterprises announces consolidated results for Q3 & 9M FY2020 ended December 31, 2019
Oct 21,2019: Piramal Enterprises announces consolidated results for the second quarter & half year ended September 30, 2019
Jul 30,2019: Piramal Enterprises announces consolidated results for the quarter ended June 30, 2019
May 07,2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board
Feb 21,2019: Supreme Court exempts Saridon from the list of banned FDCs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Piramal Enterprises Ltd - Key Facts
Piramal Enterprises Ltd - Key Employees
Piramal Enterprises Ltd - Key Employee Biographies
Piramal Enterprises Ltd - Major Products and Services
Piramal Enterprises Ltd - History
Piramal Enterprises Ltd - Company Statement
Piramal Enterprises Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Piramal Enterprises Ltd - Business Description
Business Segment: Financial services
Overview
Performance
Key Stats
Business Segment: Others
Performance
Business Segment: Pharma
Overview
Performance
Key Stats
R&D Overview
Piramal Enterprises Ltd - Corporate Strategy
Piramal Enterprises Ltd - SWOT Analysis
SWOT Analysis - Overview
Piramal Enterprises Ltd - Strengths
Piramal Enterprises Ltd - Weaknesses
Piramal Enterprises Ltd - Opportunities
Piramal Enterprises Ltd - Threats
Piramal Enterprises Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Piramal Enterprises Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Piramal Enterprises announces consolidated results for Q3 & 9M FY2020 ended December 31, 2019
Oct 21, 2019: Piramal Enterprises announces consolidated results for the second quarter & half year ended September 30, 2019
Jul 30, 2019: Piramal Enterprises announces consolidated results for the quarter ended June 30, 2019
May 07, 2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board
Feb 21, 2019: Supreme Court exempts Saridon from the list of banned FDCs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables

 
Piramal Enterprises Ltd, Key Facts
Piramal Enterprises Ltd, Key Employees
Piramal Enterprises Ltd, Key Employee Biographies
Piramal Enterprises Ltd, Major Products and Services
Piramal Enterprises Ltd, History
Piramal Enterprises Ltd, Subsidiaries
Piramal Enterprises Ltd, Joint Venture
Piramal Enterprises Ltd, Key Competitors
Piramal Enterprises Ltd, Ratios based on current share price
Piramal Enterprises Ltd, Annual Ratios
Piramal Enterprises Ltd, Annual Ratios (Cont...1)
Piramal Enterprises Ltd, Annual Ratios (Cont...2)
Piramal Enterprises Ltd, Interim Ratios
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Piramal Enterprises Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures

 
Piramal Enterprises Ltd, Performance Chart (2016 - 2020)
Piramal Enterprises Ltd, Ratio Charts
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Piramal Enterprises Ltd (PEL) - Medical Equipment - Deals and Alliances Profile.

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd is a provider of medicines and healthcare finance services. The company offers contract manufacturing and development services. It provides pharma solutions, critical

USD 250 View Report

Piramal Enterprises Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Piramal Enterprises Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Piramal Enterprises Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

HL Global Enterprises Ltd - Strategy, SWOT and Corporate Finance Report

HL Global Enterprises Ltd - Strategy, SWOT and Corporate Finance ReportHL Global Enterprises Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Zensun Enterprises Ltd - Strategy, SWOT and Corporate Finance Report

Zensun Enterprises Ltd - Strategy, SWOT and Corporate Finance ReportZensun Enterprises Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available